You may have heard of evidence gap maps – they have been used in health, social and environmental research for a while now. But, let’s be honest, is it possible some of us glaze over when hearing the words ‘evidence’, ‘gap’ and ‘map’ linked together?
A new study, published in The Lancet Neurology, has revealed an optimal approach to lowering elevated blood pressure (BP) for treating patients with acute stroke due to spontaneous bleeding in the brain (intracerebral haemorrhage or ICH), the most serious type of stroke.
In what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, UNSW Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program designed to accelerate and scale up health focused start-ups. This programme is called Health10x.
Each year at least 5000 Australians die from sepsis – a life-threatening organ dysfunction due to infection – but Australia has no national action plan to coordinate public awareness campaigns and treatment bundles, according to the authors of a Perspective published today by the Medical Journal of Australia.
Wang Du is a diabetes Research Fellow at the George Institute, China. She is also the Assistant to the Chairman of the International Diabetes Federation (IDF), Western Pacific Region. Let us hear more about her story.
Including fixed dose combinations on Essential Medicine List will improve availability, affordability for 1 billion
The George Institute for Global Health welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization’s (WHO) Essential Medicines List (EML) in response to an application filed by Resolve to Save Lives (RTSL), an initiative of vital strategies, the George Institute and other partners.
Co-founder and Principal Director of The George Institute for Global Health, Professor Stephen MacMahon, has been selected as a finalist for the prestigious Eureka Prize for Leadership in Innovation and Science.